Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 198
Titolo Data di pubblicazione Autore(i) File
Targeting nicotinamide N-methyltransferase decreased aggressiveness of osteosarcoma cells 1-gen-2024 Serritelli, En; Sartini, D; Campagna, R; Pozzi, V; Martin, Ni; van Haren, Mj; Salvolini, E; Cecati, M; Rubini, C; Emanuelli, M
Contribution of the Paraoxonase-2 Enzyme to Cancer Cell Metabolism and Phenotypes 1-gen-2024 Campagna, R; Serritelli, En; Salvolini, E; Schiavoni, V; Cecati, M; Sartini, D; Pozzi, V; Emanuelli, M
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 1-gen-2024 Pozzi, V; Molinelli, E; Campagna, R; Serritelli, En; Cecati, M; De Simoni, E; Sartini, D; Goteri, G; Martin, Ni; van Haren, Mj; Salvolini, E; Simonetti, O; Offidani, A; Emanuelli, M
Involvment of the enzyme nicotinamide N-methyltransferase in proliferation, invasive capacity and chemosensitivity of human osteosarcoma. 1-gen-2023 Serritelli, En; Pozzi, V; Campagna, R; Sartini, D; Salvolini, E; Rubini, C; Emanuelli, M
Exploring the role of paraoxonase-2 in human clear cell renal cell carcinoma: in vitro effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 1-gen-2023 Campagna, R; Schiavoni, V; Pozzi, V; Sartini, D; Milanese, G; Galosi, Ab; Emanuelli, M; Salvolini, E
Nicotinamide N-methyltransferase: a key enzyme of pyridine metabolism and a target for human osteosarcoma treatment 1-gen-2023 Campagna, R; Serritelli, E. N.; Pozzi, V; Sartini, D; Salvolini, E; Rubini, C; Goteri, G; Emanuelli, M
Enhanced expression of nicotinamide N-methyltransferase in human osteosarcoma: potential role in tumor growth and chemoresistance 1-gen-2023 Serritelli, En; Pozzi, V; Campagna, R; Sartini, D; Salvolini, E; Rubini, C; Goteri, G; Emanuelli, M
Nicotinamide N-methyltransferase, a promising marker for human Merkel cell carcinoma 1-gen-2023 Pozzi, V; Molinelli, E; Campagna, R; Serritelli, En; Cecati, M; Sartini, D; Goteri, G; Salvolini, E; Simonetti, O; Offidani, A; Emanuelli, M
Paraoxonase-2 is upregulated in triple negative breast cancer and contributes to tumor progression and chemoresistance 1-gen-2023 Campagna, R; Pozzi, V; Giorgini, S; Morichetti, D; Goteri, G; Sartini, D; Serritelli, En; Emanuelli, M
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 1-gen-2023 Sartini, Davide; Molinelli, Elisa; Pozzi, Valentina; Campagna, Roberto; Salvolini, Eleonora; Rubini, Corrado; Goteri, Gaia; Simonetti, Oriana; Campanati, Anna; Offidani, Annamaria; Emanuelli, Monica
Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies 1-gen-2023 Schiavoni, V; Campagna, R; Pozzi, V; Cecati, M; Milanese, G; Sartini, D; Salvolini, E; Galosi, Ab; Emanuelli, M
Paraoxonase-2 expression in oral squamous cell carcinoma 1-gen-2023 Campagna, R; Pozzi, V; Salvucci, A; Togni, L; Mascitti, M; Sartini, D; Salvolini, E; Santarelli, A; Lo Muzio, L; Emanuelli, M
The Effect and the Potential Use of Magnetic–Dam Barrier in Guided Bone Regeneration: A Laboratory Study 1-gen-2023 Memè, L; Bambini, F; Gallusi, G; Sartini, D; Pozzi, V; Emanuelli, M; Strappa, Em; Mummolo, S
Enzymes Dysregulation in Cancer: From Diagnosis to Therapeutical Approaches 1-gen-2023 Pozzi, V; Campagna, R; Sartini, D; Emanuelli, M
Role Played by Paraoxonase-2 Enzyme in Cell Viability, Proliferation and Sensitivity to Chemotherapy of Oral Squamous Cell Carcinoma Cell Lines 1-gen-2023 Campagna, R; Belloni, A; Pozzi, V; Salvucci, A; Notarstefano, V; Togni, L; Mascitti, M; Sartini, D; Giorgini, E; Salvolini, E; Santarelli, A; Lo Muzio, L; Emanuelli, M
Nicotinamide N-methyltransferase, a promising marker for human osteosarcoma 1-gen-2022 Pozzi, V; Serritelli, En; Campagna, R; Sartini, D; Salvolini, E; Rubini, C; Emanuelli, M
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 1-gen-2022 Campagna, R; Bacchetti, T; Salvolini, E; Pozzi, V; Serritelli, E; Giorgini, S; Molinelli, E; Simonetti, O; Sartini, D; Campanati, A; Ferretti, G; Goteri, G; Offidani, A; Emanuelli, M
FTIRM: an analytical approach to test the effectiveness of cisplatin treatment on PON2 silenced otscc cells 1-gen-2022 Belloni, A; Notarstefano, V; Campagna, R; Pozzi, V; Sartini, D; Giorgini, E; Emanuelli, M
Role of paraoxonase-2 in triple-negative breast cancer: effect of shRNA-mediated gene silencing on cell proliferation and chemosensitivity 1-gen-2022 Campagna, R; Giorgini, S; Morichetti, D; Sartini, D; Pozzi, V; Goteri, G; Emanuelli, M
Paraoxonase-2 (PON2) is upregulated in triple negative breast cancer and contributes to the tumor progression and chemoresistance 1-gen-2022 Campagna, R; Giorgini, S; Morichetti, D; Sartini, D; Pozzi, V; Goteri, G; Emanuelli, M.
Mostrati risultati da 1 a 20 di 198
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile